August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

Two highlighted clinical studies: the first addresses the effect of combining a SGLT2 inhibitor and a MRA on proteinuria; the second considers vascular reactivity as a risk factor for cerebral hypoxia when blood pressure falls during dialysis treatments.

Episode metadata supplied by the publisher feed · Published Dec 30, 2022

Embed this episode

Attribution link and audio player

Ready to play

August 2022 JASN Highlights: Addressing CKD Progression and Hazards of Intradialytic Hypotension

0:00 8:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of JASN Podcast?

This episode is 8 minutes long.

When was this JASN Podcast episode published?

This episode was published on December 30, 2022.

Can I download this JASN Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!